Surveys from 2020 showed that about 1 in 4 adults with recent chronic pain reported using pharmacologic therapies only, showing a need to increase nonpharmacologic therapy use, according to the study authors.
21 Nov 2023
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
1 Nov 2023
Patients whose urine drug screens in the three weeks after beginning treatment for opioid use disorder (OUD) were negative for opioids had a 13% risk of returning to opioid use compared with 85% for those with three weeks of opioid-positive or missing results.
10 Oct 2023
A cross-sectional study of U.S. insurance claims found that buprenorphine initiation during a telehealth visit was associated with a 36% lower overdose rate than in person and that patients in the former group were more likely to refill their prescriptions.
12 Sep 2023
This column reviews recent recalls, alerts, and approvals.
1 Jun 2023
This may be due to the sensitivity of the screening instrument, compounded by the stigma of opioid use disorder; addressing the latter may increase the instrument's sensitivity, the authors suggest.
17 Oct 2023
The U.S. government no longer requires an X waiver to treat patients with buprenorphine for opioid use disorder.
1 Mar 2023
A trial in the U.K. randomly assigned patients with chronic noncancer pain to receive a group-based educational intervention or usual care and measured effects on opioid use and perceived pain at 12 months.
30 May 2023
An 87-year-old woman is evaluated for a 1-year history of bothersome insomnia. She reports taking up to 2 hours to fall asleep. She also feels that her sleep is less refreshing. What is the most appropriate treatment?
21 Nov 2023
Doctors continue to be frustrated by their patients' chronic pain problems, due to a lack of evidence on opioids' long-term effectiveness and strong evidence of potential harms.
1 Apr 2015